NCT06362239

Brief Summary

The purpose of this study is to test the hypothesis that the addition of home-based hospice and palliative care (HBHPC) will provide a reduction in health care utilization, improve quality of life, and facilitate goal-concordant care that is superior to inpatient and clinic pediatric palliative care (PPC) alone.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Aug 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Aug 2024Oct 2027

First Submitted

Initial submission to the registry

March 28, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 12, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

October 29, 2025

Status Verified

October 1, 2025

Enrollment Period

2 years

First QC Date

March 28, 2024

Last Update Submit

October 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hospital Utilization Differences

    Hospital utilization including ICU days, inpatient hospital days, ED visits, quality of life

    At enrollment and every three months for a two year period for a maximum of 24 months

Secondary Outcomes (2)

  • Demographic Differences

    Identified at time of study enrollment and does not require ongoing measurement.

  • Location of death differences

    From date of enrollment to date of death (if occurred) over study enrollment for a maximum period of 24 months.

Study Arms (2)

High-access home-based hospice and palliative care (HBHPC)

Patients with high-access to home-based hospice and palliative care (HBHPC) enrolled from three sites: Nationwide Children's Hospital, Columbus, OH (NCH); Akron Children's Hospital, Akron, OH (ACH); and Medical University of South Carolina, Charleston, SC (MUSC).

Other: Study Surveys

Low-access home-based hospice and palliative care (HBHPC)

Patients with low-access to home-based hospice and palliative care (HBHPC) (i.e., primarily or exclusively hospital-based services) enrolled from two sites: Nemours Children's Hospital, Wilmington, DE (Nemours); and Texas Children's Hospital, Houston, TX (TCH).

Other: Study Surveys

Interventions

Participants will complete study surveys as their participation in the research study. Study staff will collect clinical and demographic information from the electronic medical records. The enrollment in this intervention will not be decided by research enrollment, but would naturally occur regardless of enrollment in the study.

High-access home-based hospice and palliative care (HBHPC)Low-access home-based hospice and palliative care (HBHPC)

Eligibility Criteria

AgeUp to 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children and young adults between the ages of 0-19 years old. One cohort of those that receive HBHPC combined with inpatient/clinic based palliative care and the other cohort will be those that receive only inpatient/clinic based palliative care. The cohorts will not be random in assignment and will be determined by accessibility to HBHPC. The study will include three sites with high access to HBHPC and two sites with limited access to HBHPC. Patients will be allowed to transition between arms should they gain access to HBHPC.

You may qualify if:

  • Patients aged 0-19
  • Patients seen as new referral or follow up visit by PPC (Pediatric Palliative Care) team in either the inpatient or clinic context and expected to require at least twice-annual palliative care visits

You may not qualify if:

  • Followed by PPC regardless of context for \>6 months prior to enrollment
  • Patient no longer clinically needs long term PPC follow up
  • Child / young adult is in custody of state or county

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nationwide Children's Hospital

Columbus, Ohio, 43082, United States

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 28, 2024

First Posted

April 12, 2024

Study Start

August 1, 2024

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

October 1, 2027

Last Updated

October 29, 2025

Record last verified: 2025-10

Locations